Logo
x

Search

Subscribe Now

Inovio

INOVIO Receives the US FDA’s Breakthrough Therapy Designation for INO-3107 to Treat Recurrent Respiratory Papillomatosis

INOVIO Receives the US FDA’s Breakthrough Therapy Designation for INO-3107 to Treat Recurrent Respiratory Papillomatosis

  • September 8, 2023
PharmaShots Weekly Snapshots (June 07 - 11, 2021)

PharmaShots Weekly Snapshots (June 07 - 11, 2021)

  • June 11, 2021
Insights+: COVID-19 Healthcare News Monthly Updates - December 2020

Insights+: COVID-19 Healthcare News Monthly Updates - December 2020

  • December 31, 2020
Inovio Reports FDA's Partial Clinical Hold on P-II/III Trial of INO-4800 Against COVID-19

Inovio Reports FDA's Partial Clinical Hold on P-II/III Trial of INO-4800 Against COVID-19

  • September 29, 2020
PharmaShots' Key Highlights of Second Quarter 2020

PharmaShots' Key Highlights of Second Quarter 2020

  • July 7, 2020
Top COVID-19 Deals (Part III): Biopharma and Govt. Institutions

Top COVID-19 Deals (Part III): Biopharma and Govt. Institutions

  • June 26, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.